Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

Delayed Quote. Delayed  - 09/28 10:02:42 pm
23.75 USD   +0.13%
09/28 GLOBAL DRUG ELU : BOSTON SCIENTIFIC, JOHNSON and JOHNSON, ABBOTT LAB..
09/28 GLOBAL DRUG DEV : Boston Scientific, Medtronic, Roche Diagnostics, A..
09/28 BOSTON SCIENTIF : will pay $210M for endoscopy maker EndoChoice
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Global Drug Eluting Stents (DES) Market 2016: BOSTON SCIENTIFIC, JOHNSON and JOHNSON, ABBOTT LABORATORIES, MEDTRONIC.INC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2016 | 09:32pm CEST

Market.Biz has recently launched new Market Research Report on "Drug Eluting Stents (DES) Market" is a in-depth and professional survey on Drug Eluting Stents (DES) Market.Pune, Maharashtra -- (SBWIRE) -- 09/28/2016 -- The research study Global Drug Eluting Stents (DES) Industry offers strategic assessment of the Global Drug Eluting Stents (DES) market. The industry report focuses on the growth opportunities, which will help the Global Drug Eluting Stents (DES) industry to expand operations in the existing markets.

Major Manufacturers Analysis of Drug Eluting Stents (DES):

1. BOSTON SCIENTIFIC
2. JOHNSON & JOHNSON
3. ABBOTT LABORATORIES
4. MEDTRONIC.INC
5. BETRIEBSKRANKENKASSE DER B. BRAUN MELSUNGEN
6. BIORING SA
7. CORNOVA
8. BALTON LTD

(with Company Profile, Product Picture and Specifications, Sales Volume, Sales Revenue, Sale Price and Gross Margin and Contact Information)-

Do Inquiry Before Purchasing Report Here: https://market.biz/report/global-drug-eluting-stents-des-market-2016/16735/#inquiry

The study assess new product and service positioning strategies in the Global Drug Eluting Stents (DES) market. Furthermore, the new and evolving technologies and their impact on the Drug Eluting Stents (DES) market is analyzed in detail in this report.

After that, Drug Eluting Stents (DES) industry development policies as well as plans are discussed and manufacturing processes as well as cost structures for Drug Eluting Stents (DES) market. This report "Worldwide Drug Eluting Stents (DES) Market" also states import/export, supply and consumption figures and Drug Eluting Stents (DES) market cost, price, revenue and Drug Eluting Stents (DES) market's gross margin by regions (United States, EU, China and Japan), as well as other regions can be added in Drug Eluting Stents (DES) Market area.

The leading players in the Global Drug Eluting Stents (DES) market have been profiled in this report. The key Drug Eluting Stents (DES) market players with their business overview, marketing strategies, strategic alliances and acquisitions are included in this Drug Eluting Stents (DES) market report. The report (Worldwide Drug Eluting Stents (DES) Market) features significant industry insights, Drug Eluting Stents (DES) market expectations, and key developments, which will help firms operating in the Drug Eluting Stents (DES) market to make informed business decisions.

Detailed business overview, Drug Eluting Stents (DES) market revenue analysis, strategies, and SWOT analysis of the key players has been included in the report. Players in the Global Drug Eluting Stents (DES) market are aiming to expand their operations to emerging regions. Further, companies in the Drug Eluting Stents (DES) market are focusing on innovation and positioning their products at competitive prices. An in-depth Drug Eluting Stents (DES) supply chain analysis in the report will give readers a better understanding of the Drug Eluting Stents (DES) market.

Purchase Report Here To Get Instant Access To the Report: https://market.biz/report/global-drug-eluting-stents-des-market-2016/16735/

The report also delivers a detailed segment-based assessment of the Global Drug Eluting Stents (DES) market. The segments along with their sub-segments have been analyzed in this report. Furthermore, the report (Worldwide Drug Eluting Stents (DES) Industry) evaluates the trends that will help to fuel the growth of the individual sectors. The key segments of the Global Drug Eluting Stents (DES) market along with their market forecasts both in terms of revenue and volume have been covered in the Drug Eluting Stents (DES) market research study. The worldwide Drug Eluting Stents (DES) market report also talks about the emerging geographical sectors in Drug Eluting Stents (DES) market and the trends that will drive the industry across these regional segments.For more information on this press release visit: http://www.sbwire.com/press-releases/global-drug-eluting-stents-des-market-2016-boston-scientific-johnson-and-johnson-abbott-laboratories-medtronicinc-727527.htm

Media Relations Contact

Robert Martin
Sr Manager
Market.Biz
Telephone: 857-239-0696
Email: Click to Email Robert Martin
Web: https://market.biz/report/global-drug-eluting-stents-des-market-2016/16735/

© ReleaseWire, source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BOSTON SCIENTIFIC CORPORAT
09/28 GLOBAL DRUG ELUTING STENTS (DES) MAR : BOSTON SCIENTIFIC, JOHNSON and JOHNSON, A..
09/28 GLOBAL DRUG DEVICE COMBINATION PRODU : Boston Scientific, Medtronic, Roche Diagn..
09/28 BOSTON SCIENTIFIC : will pay $210M for endoscopy maker EndoChoice
09/27 ENDOCHOICE : Boston Scientific buys EndoChoice for $210m
09/27 MEDX : medical incubator opens its doors
09/27DJBOSTON SCIENTIFIC : to Buy EndoChoice
09/27 BOSTON SCIENTIFIC CORP : Other Events, Financial Statements and Exhibits (form 8..
09/24 BOSTON SCIENTIFIC : For medical device makers, return elusive for longer battery..
09/22 BOSTON SCIENTIFIC : $33,350 Federal Contract Awarded to Boston Scientific
09/20 MEDX : medical incubator opens its doors
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
09/27 Disney Prepping Twitter Bid
09/27 Boston Scientific acquires platform GI firm EndoChoice for $8 a share
09/19 Game Plan For The Week - Cramer's Mad Money (9/16/16)
09/15 Rox Medical Thrives Under Pressure
09/07 U.S. Deals Dominate Medtech M&A
Advertisement
Financials ($)
Sales 2016 8 311 M
EBIT 2016 1 742 M
Net income 2016 595 M
Debt 2016 4 177 M
Yield 2016 -
P/E ratio 2016 47,98
P/E ratio 2017 24,42
EV / Sales 2016 4,39x
EV / Sales 2017 3,91x
Capitalization 32 318 M
More Financials
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 27,5 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORP..28.80%32 318
THERMO FISHER SCIENTIF..11.84%62 546
PHILIPS11.84%28 298
INTUITIVE SURGICAL, IN..31.42%27 629
ILLUMINA, INC.-5.71%26 532
EDWARDS LIFESCIENCES C..52.52%25 643
More Results